Detalhe da pesquisa
1.
Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
Gynecol Oncol
; 162(2): 284-291, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083029
2.
Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
Acta Oncol
; 58(6): 828-837, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30810443
3.
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Lancet Oncol
; 19(12): 1680-1687, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413383
4.
Chromatin organisation and cancer prognosis: a pan-cancer study.
Lancet Oncol
; 19(3): 356-369, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29402700
5.
Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.
Acta Oncol
; 56(5): 675-681, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28447564
6.
A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway.
Acta Obstet Gynecol Scand
; 96(10): 1162-1169, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28795770
7.
[Properties of cancer cell DNA affects the prognosis]. / Egenskaper ved kreftcellenes DNA påvirker prognosen.
Tidsskr Nor Laegeforen
; 137(19)2017 10 17.
Artigo
em Norueguês
| MEDLINE | ID: mdl-29043733
8.
Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab.
Br J Cancer
; 115(2): 228-35, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351218
9.
Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas.
Cytometry A
; 87(4): 315-25, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25483227
10.
Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO).
BMC Cancer
; 14: 68, 2014 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24498853
11.
Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling.
J Pathol
; 230(1): 59-69, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23335387
12.
Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer.
Eur J Cancer
; 200: 113584, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330767
13.
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
N Engl J Med
; 363(10): 943-53, 2010 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20818904
14.
Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy.
Gynecol Oncol
; 131(2): 437-44, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23994107
15.
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.
Cancers (Basel)
; 15(6)2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980708
16.
Diagnosis and treatment of sarcoma of the uterus. A review.
Acta Oncol
; 51(6): 694-705, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22793037
17.
Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.
PLoS Genet
; 5(11): e1000719, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19911042
18.
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer.
Radiother Oncol
; 176: 17-24, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113778
19.
miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer.
Mol Oncol
; 16(6): 1402-1419, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064630
20.
Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers.
Acta Oncol
; 50(6): 859-65, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21767185